West Pharmaceutical Services Debt to Equity Ratio 2006-2018 | WST
Current and historical debt to equity ratio values for West Pharmaceutical Services (WST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. West Pharmaceutical Services debt/equity for the three months ending September 30, 2018 was 0.15.
| West Pharmaceutical Services Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2018-09-30 |
$0.20B |
$1.35B |
0.15 |
| 2018-06-30 |
$0.20B |
$1.28B |
0.15 |
| 2018-03-31 |
$0.20B |
$1.31B |
0.15 |
| 2017-12-31 |
$0.20B |
$1.28B |
0.15 |
| 2017-09-30 |
$0.20B |
$1.32B |
0.15 |
| 2017-06-30 |
$0.20B |
$1.24B |
0.16 |
| 2017-03-31 |
$0.19B |
$1.17B |
0.17 |
| 2016-12-31 |
$0.23B |
$1.12B |
0.20 |
| 2016-09-30 |
$0.23B |
$1.14B |
0.20 |
| 2016-06-30 |
$0.23B |
$1.11B |
0.21 |
| 2016-03-31 |
$0.23B |
$1.07B |
0.21 |
| 2015-12-31 |
$0.23B |
$1.02B |
0.22 |
| 2015-09-30 |
$0.23B |
$1.00B |
0.23 |
| 2015-06-30 |
$0.23B |
$0.99B |
0.23 |
| 2015-03-31 |
$0.23B |
$0.94B |
0.25 |
| 2014-12-31 |
$0.31B |
$0.96B |
0.32 |
| 2014-09-30 |
$0.32B |
$0.97B |
0.33 |
| 2014-06-30 |
$0.36B |
$0.97B |
0.37 |
| 2014-03-31 |
$0.39B |
$0.94B |
0.42 |
| 2013-12-31 |
$0.37B |
$0.91B |
0.41 |
| 2013-09-30 |
$0.38B |
$0.84B |
0.46 |
| 2013-06-30 |
$0.40B |
$0.78B |
0.50 |
| 2013-03-31 |
$0.43B |
$0.75B |
0.57 |
| 2012-12-31 |
$0.38B |
$0.73B |
0.52 |
| 2012-09-30 |
$0.36B |
$0.72B |
0.51 |
| 2012-06-30 |
$0.30B |
$0.68B |
0.44 |
| 2012-03-31 |
$0.30B |
$0.70B |
0.42 |
| 2011-12-31 |
$0.30B |
$0.66B |
0.46 |
| 2011-09-30 |
$0.32B |
$0.69B |
0.47 |
| 2011-06-30 |
$0.37B |
$0.70B |
0.53 |
| 2011-03-31 |
$0.37B |
$0.66B |
0.55 |
| 2010-12-31 |
$0.36B |
$0.63B |
0.57 |
| 2010-09-30 |
$0.37B |
$0.63B |
0.58 |
| 2010-06-30 |
$0.36B |
$0.57B |
0.63 |
| 2010-03-31 |
$0.35B |
$0.58B |
0.60 |
| 2009-12-31 |
$0.38B |
$0.58B |
0.66 |
| 2009-09-30 |
$0.39B |
$0.57B |
0.70 |
| 2009-06-30 |
$0.39B |
$0.53B |
0.73 |
| 2009-03-31 |
$0.38B |
$0.49B |
0.79 |
| 2008-12-31 |
$0.38B |
$0.49B |
0.78 |
| 2008-09-30 |
$0.38B |
$0.53B |
0.72 |
| 2008-06-30 |
$0.40B |
$0.55B |
0.73 |
| 2008-03-31 |
$0.42B |
$0.51B |
0.82 |
| 2007-12-31 |
$0.40B |
$0.49B |
0.81 |
| 2007-09-30 |
$0.39B |
$0.48B |
0.82 |
| 2007-06-30 |
$0.38B |
$0.49B |
0.78 |
| 2007-03-31 |
$0.38B |
$0.46B |
0.82 |
| 2006-12-31 |
$0.24B |
$0.42B |
0.57 |
| 2006-09-30 |
$0.24B |
$0.40B |
0.60 |
| 2006-06-30 |
$0.26B |
$0.39B |
0.67 |
| 2006-03-31 |
$0.27B |
$0.36B |
0.75 |
| 2005-12-31 |
$0.28B |
$0.34B |
0.83 |
| 2005-09-30 |
$0.26B |
$0.33B |
0.80 |
| 2005-06-30 |
$0.28B |
$0.32B |
0.88 |
| 2005-03-31 |
$0.15B |
$0.31B |
0.50 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$8.159B |
$1.599B |
|
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
|
